For: | Jain L, Kaur J, Ayub S, Ansari D, Ahmed R, Dada AQ, Ahmed S. Fentanyl and xylazine crisis: Crafting coherent strategies for opioid overdose prevention. World J Psychiatry 2024; 14(6): 760-766 [PMID: 38984339 DOI: 10.5498/wjp.v14.i6.760] |
---|---|
URL: | https://www.wjgnet.com/2220-3206/full/v14/i6/760.htm |
Number | Citing Articles |
1 |
Luz A. Silva-Torres, Ashraf Mozayani. Xylazine abuse, the growing risk: A review of its effects, upsurge use and associated fatalities in the USA and Puerto Rico. Journal of Forensic and Legal Medicine 2024; 108: 102780 doi: 10.1016/j.jflm.2024.102780
|
2 |
Domenico Iacopetta, Alessia Catalano, Francesca Aiello, Inmaculada Andreu, Maria Stefania Sinicropi, Giovanni Lentini. Xylazine, a Drug Adulterant Whose Use Is Spreading in the Human Population from the U.S. to the U.K. and All Europe: An Updated Review. Applied Sciences 2025; 15(6): 3410 doi: 10.3390/app15063410
|
3 |
Thomas L Miller, Jeanette Mathews, George C Dungan, Joseph V Pergolizzi, Robert B Raffa. ENA-001 Reverses Xylazine/Fentanyl Combination-Induced Respiratory Depression in Rats: A Qualitative Pilot Study. Cureus 2024; doi: 10.7759/cureus.74826
|
4 |
Donald E. Greydanus, Ahsan Nazeer, Dilip R. Patel. Opioid use and abuse in adolescents and young adults; dealing with science, laws and ethics: Charming the COBRAS. Disease-a-Month 2025; 71(3): 101853 doi: 10.1016/j.disamonth.2025.101853
|